keyword
https://read.qxmd.com/read/38652268/osiris-gene-family-defines-the-cuticle-nanopatterns-of-drosophila
#1
JOURNAL ARTICLE
Zhengkuan Sun, Sachi Inagaki, Keita Miyoshi, Kuniaki Saito, Shigeo Hayashi
Nanostructures of pores and protrusions in the insect cuticle modify molecular permeability and surface wetting, and help insects sense various environmental cues. However, the cellular mechanisms that modify cuticle nanostructures are poorly understood. Here, we elucidate how insect-specific Osiris family genes are expressed in various cuticle-secreting cells in the Drosophila head during the early stages of cuticle secretion and cover nearly the entire surface of the head epidermis. Furthermore, we demonstrate how each sense organ cell with various cuticular nanostructures expressed a unique combination of Osiris genes...
April 23, 2024: Genetics
https://read.qxmd.com/read/38651890/genome-wide-identification-of-the-hsp70-gene-family-in-penaeus-chinensis-and-their-response-to-environmental-stress
#2
JOURNAL ARTICLE
Xinran Li, Miao Zhu
The heat shock protein 70 (HSP70) gene family plays a crucial role in the response of organisms to environmental stress. However, it has not been systematically characterized in shrimp. In this study, we identified 25 PcHsp70 genes in the Penaeus chinensis genome. The encoded proteins were categorized into six subgroups based on phylogenetic relationships. Tandem duplication was the main driver of amplification in the PcHsp70 family, and the genes have experienced strong purifying selection during evolution...
April 23, 2024: Animal Biotechnology
https://read.qxmd.com/read/38645681/a-mutation-in-the-brassinosteroid-biosynthesis-gene-cpdwf5-disrupts-vegetative-and-reproductive-development-and-the-salt-stress-response-in-squash-cucurbita-pepo
#3
JOURNAL ARTICLE
Sonsoles Alonso, Gustavo Cebrián, Keshav Gautam, Jessica Iglesias-Moya, Cecilia Martínez, Manuel Jamilena
A Cucurbita pepo mutant with multiple defects in growth and development has been identified and characterized. The mutant dwfcp displayed a dwarf phenotype with dark green and shrinking leaves, shortened internodes and petioles, shorter but thicker roots and greater root biomass, and reduced fertility. The causal mutation of the phenotype was found to disrupt gene Cp4.1LG17g04540 , the squash orthologue of the Arabidopsis brassinosteroid (BR) biosynthesis gene DWF5 , encoding for 7-dehydrocholesterol reductase...
April 2024: Horticulture Research
https://read.qxmd.com/read/38644693/chronic-neutrophilic-leukemia-and-atypical-chronic-myeloid-leukemia-2024-update-on-diagnosis-genetics-risk-stratification-and-management
#4
REVIEW
Natasha Szuber, Attilio Orazi, Ayalew Tefferi
Chronic neutrophilic leukemia (CNL) is a rare BCR::ABL1-negative myeloproliferative neoplasm (MPN) defined by persistent mature neutrophilic leukocytosis and bone marrow granulocyte hyperplasia. Atypical chronic myeloid leukemia (aCML) (myelodysplastic "[MDS]/MPN with neutrophilia" per World Health Organization [WHO]) is a MDS/MPN overlap disorder featuring dysplastic neutrophilia and circulating myeloid precursors. Both manifest with frequent hepatosplenomegaly and less commonly, bleeding, with high rates of leukemic transformation and death...
April 21, 2024: American Journal of Hematology
https://read.qxmd.com/read/38644649/inhaled-pollutants-of-the-gero-exposome-and-later-life-health
#5
JOURNAL ARTICLE
Caleb E Finch, Max A Thorwald
Inhaled air pollutants (AirP) comprise extraordinarily diverse particles, volatiles, and gases from traffic, wildfire, cigarette smoke, dust, and various other sources. These pollutants contain numerous toxic components which collectively differ in relative levels of components, but broadly share chemical classes. Exposure and health outcomes from AirP are complex, depending on pollutant source, duration of exposure, and socioeconomic status. We discuss examples in the current literature on organ responses to AirP, with a focus on lung, arteries, and brain...
April 22, 2024: Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
https://read.qxmd.com/read/38639672/challenges-and-opportunities-for-access-to-advanced-therapy-medicinal-products-in-brazil
#6
JOURNAL ARTICLE
Camile Giaretta Sachetti, Augusto Barbosa, Antonio Carlos Campos de Carvalho, Denizar Vianna Araujo, Everton Nunes da Silva
BACKGROUND AIMS: The marketing authorization of Advanced Therapy Medicinal Products (ATMPs) in Brazil is recent. The features of these therapies impose specialized regulatory action and are consequently challenging for developers. The goal of this study was to identify the industry's experience in clinical development, marketing authorization and access to ATMPs through the Unified Health System (SUS, acronym in Portuguese), from a regulatory perspective. METHODS: A survey containing structured questions was conducted among research participants who work at companies that commercialize ATMPs...
March 29, 2024: Cytotherapy
https://read.qxmd.com/read/38638432/cutting-edge-of-genetically-modified-pigs-targeting-complement-activation-for-xenotransplantation
#7
REVIEW
Qin Sun, Si-Yuan Song, Jiabao Ma, Danni Li, Yiping Wang, Zhengteng Yang, Yi Wang
In the quest to address the critical shortage of donor organs for transplantation, xenotransplantation stands out as a promising solution, offering a more abundant supply of donor organs. Yet, its widespread clinical adoption remains hindered by significant challenges, chief among them being immunological rejection. Central to this issue is the role of the complement system, an essential component of innate immunity that frequently triggers acute and chronic rejection through hyperacute immune responses. Such responses can rapidly lead to transplant embolism, compromising the function of the transplanted organ and ultimately causing graft failure...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38634010/technical-note-on-the-quality-of-dna-sequencing-for-the-molecular-characterisation-of-genetically-modified-plants
#8
JOURNAL ARTICLE
Adrián César-Razquin, Josep Casacuberta, Tamas Dalmay, Silvia Federici, Sara Jacchia, Dafni Maria Kagkli, Simon Moxon, Nikoletta Papadopoulou
As part of the risk assessment (RA) requirements for genetically modified (GM) plants, according to Regulation (EU) No 503/2013 and the EFSA guidance on the RA of food and feed from GM plants (EFSA GMO Panel 2011), applicants need to perform a molecular characterisation of the DNA sequences inserted in the GM plant genome. This Technical Note to the applicants puts together requirements and recommendations for the quality assessment of the methodology, analysis and reporting when DNA sequencing is used for the molecular characterisation of GM plants...
April 2024: EFSA journal
https://read.qxmd.com/read/38634009/safety-evaluation-of-the-food-enzyme-leucyl-aminopeptidase-from-the-genetically-modified-aspergillus-oryzae-strain-nzym-bu
#9
JOURNAL ARTICLE
Claude Lambré, José Manuel Barat Baviera, Claudia Bolognesi, Pier Sandro Cocconcelli, Riccardo Crebelli, David Michael Gott, Konrad Grob, Evgenia Lampi, Marcel Mengelers, Alicja Mortensen, Gilles Rivière, Inger-Lise Steffensen, Christina Tlustos, Henk Van Loveren, Laurence Vernis, Holger Zorn, Magdalena Andryszkiewicz, Erik Boinowitz, Boet Glandorf, Natalia Kovalkovicova, Giulio Di Piazza, Yi Liu, Simone Lunardi, Daniele Cavanna, Yrjö Roos, Andrew Chesson
The food enzyme leucyl aminopeptidase (EC 3.4.11.1) is produced with the genetically modified Aspergillus oryzae strain NZYM-BU by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and its DNA. It is intended to be used in five food manufacturing processes. Dietary exposure to the food enzyme TOS was estimated to be up to 1.508 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern...
April 2024: EFSA journal
https://read.qxmd.com/read/38634008/safety-evaluation-of-the-food-enzyme-oryzin-from-the-non-genetically-modified-aspergillus-ochraceus-strain-ae-p
#10
JOURNAL ARTICLE
Claude Lambré, José Manuel Barat Baviera, Claudia Bolognesi, Pier Sandro Cocconcelli, Riccardo Crebelli, David Michael Gott, Konrad Grob, Evgenia Lampi, Marcel Mengelers, Alicja Mortensen, Gilles Rivière, Inger-Lise Steffensen, Christina Tlustos, Henk Van Loveren, Laurence Vernis, Holger Zorn, Yrjö Roos, Magdalena Andryszkiewicz, Daniele Cavanna, Simone Lunardi, Elsa Nielsen, Karin Norby, Giulio di Piazza, Yi Liu, Andrew Chesson
The food enzyme oryzin (EC 3.4.21.63) is produced with the non-genetically modified Aspergillus ochraceus strain AE-P by Amano Enzyme Inc. The food enzyme was considered free from viable cells of the production organism. It is intended to be used in nine food manufacturing processes. The dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be up to 0.1 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not raise a safety concern. The systemic toxicity was assessed by means of a repeated dose 90-day oral toxicity study in rats...
April 2024: EFSA journal
https://read.qxmd.com/read/38633590/recommended-tool-compounds-for-modifying-the-cystic-fibrosis-transmembrane-conductance-regulator-channel-variants
#11
REVIEW
XiaoXuan Han, Danni Li, Yimin Zhu, Elena K Schneider-Futschik
Cystic fibrosis (CF) is a genetic disorder arising from variations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, leading to multiple organ system defects. CFTR tool compounds are molecules that can modify the activity of the CFTR channel. Especially, patients that are currently not able to benefit from approved CFTR modulators, such as patients with rare CFTR variants, benefit from further research in discovering novel tools to modulate CFTR. This Review explores the development and classification of CFTR tool compounds, including CFTR blockers (CFTRinh-172, GlyH-101), potentiators (VRT-532, Genistein), correctors (VRT-325, Corr-4a), and other approved and unapproved modulators, with detailed descriptions and discussions for each compound...
April 12, 2024: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38630239/locomotor-assays-in-drosophila-larvae-and-adult-flies
#12
JOURNAL ARTICLE
Leo Tsuda, Huynh Man Anh, Hideki Yoshida
Brain defects often lead to motor dysfunctions in humans. Drosophila melanogaster has been one of the most useful organisms in the study of neuronal biology due to its similarities with humans and has contributed to a more detailed understanding of the effects of genetic dysfunctions in the brain on behavior. We herein present modified protocols for the crawling assay with larvae and the climbing assay with adult flies that are simple to perform as well as a series of commands for ImageJ to automatically analyze data for the crawling assay...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38628120/vertically-inherited-microbiota-and-environment-modifying-behaviours-conceal-genetic-variation-in-dung-beetle-life-history
#13
JOURNAL ARTICLE
Patrick T Rohner, Armin P Moczek
Diverse organisms actively manipulate their (sym)biotic and physical environment in ways that feed back on their own development. However, the degree to which these processes affect microevolution remains poorly understood. The gazelle dung beetle both physically modifies its ontogenetic environment and structures its biotic interactions through vertical symbiont transmission. By experimentally eliminating (i) physical environmental modifications and (ii) the vertical inheritance of microbes, we assess how environment modifying behaviour and microbiome transmission shape heritable variation and evolutionary potential...
April 30, 2024: Proceedings. Biological Sciences
https://read.qxmd.com/read/38618727/efficacy-and-nuances-of-precision-molecular-engineering-for-hodgkin-s-disease-to-a-gene-therapeutic-approach
#14
JOURNAL ARTICLE
Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain
Gene therapy is a particularly useful treatment for nervous system genetic diseases, including those induced especially by infectious organisms and antigens, and is being utilized to treat Hodgkin's disease (HD). Due to the possible clonal relationship between both disorders, immunotherapy directed against CD20 positive cells may be a more effective treatment in patients with persistent HD and NHL. HL growth can be inhibited both in vitro and in vivo by AdsIL-13Ralpha2. High-dose treatment combined with stem cell transplantation has been effective in treating HIV-negative lymphoma that has progressed to high-risk or relapsed disease...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38617238/the-cytokine-receptor-fn14-is-a-molecular-brake-on-neuronal-activity-that-mediates-circadian-function-in-vivo
#15
Austin Ferro, Anosha Arshad, Leah Boyd, Tess Stanley, Adrian Berisha, Uma Vrudhula, Adrian M Gomez, Jeremy C Borniger, Lucas Cheadle
UNLABELLED: To survive, organisms must adapt to a staggering diversity of environmental signals, ranging from sensory information to pathogenic infection, across the lifespan. At the same time, organisms intrinsically generate biological oscillations, such as circadian rhythms, without input from the environment. While the nervous system is well-suited to integrate extrinsic and intrinsic cues, how the brain balances these influences to shape biological function system-wide is not well understood at the molecular level...
April 2, 2024: bioRxiv
https://read.qxmd.com/read/38617195/safety-evaluation-of-the-food-enzyme-glutaminase-from-the-genetically-modified-bacillus-licheniformis-strain-nzym-jq
#16
JOURNAL ARTICLE
Claude Lambré, José Manuel Barat Baviera, Claudia Bolognesi, Pier Sandro Cocconcelli, Riccardo Crebelli, David Michael Gott, Konrad Grob, Evgenia Lampi, Marcel Mengelers, Alicja Mortensen, Gilles Rivière, Inger-Lise Steffensen, Christina Tlustos, Henk Van Loveren, Laurence Vernis, Holger Zorn, Yrjö Roos, Magdalena Andryszkiewicz, Ana Criado, Ana Gomes, Yi Liu, Daniele Cavanna, Giulio di Piazza, Andrew Chesson
The food enzyme glutaminase (l-glutamine amidohydrolase EC 3.5.1.2) is produced with the genetically modified Bacillus licheniformis strain NZYM-JQ by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The production strain met the requirements for the qualified presumption of safety (QPS). The food enzyme is free from viable cells of the production organism and its DNA. The enzyme under assessment is intended to be used in six food manufacturing processes. Dietary exposure was estimated to be up to 0...
April 2024: EFSA journal
https://read.qxmd.com/read/38617194/safety-evaluation-of-the-food-enzyme-phosphodiesterase-i-from-the-non-genetically-modified-leptographium-procerum-strain-fda
#17
JOURNAL ARTICLE
Claude Lambré, José Manuel Barat Baviera, Claudia Bolognesi, Pier Sandro Cocconcelli, Riccardo Crebelli, David Michael Gott, Konrad Grob, Evgenia Lampi, Marcel Mengelers, Alicja Mortensen, Gilles Rivière, Inger-Lise Steffensen, Christina Tlustos, Henk Van Loveren, Laurence Vernis, Holger Zorn, Yrjö Roos, Magdalena Andryszkiewicz, Daniele Cavanna, Ana Criado, Simone Lunardi, Elsa Nielsen, Karin Nørby, Yi Liu, Andrew Chesson
The food enzyme phosphodiesterase I (oligonucleotide 5'-nucleotidohydrolase; EC 3.1.4.1) is produced with the non-genetically modified Leptographium procerum strain FDA by DSM Food Specialties B.V. The food enzyme is free from viable cells of the production organism. It is intended to be used in the processing of yeast and yeast products. Dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be up to 0.171 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern...
April 2024: EFSA journal
https://read.qxmd.com/read/38616334/expanding-deep-phenotypic-spectrum-associated-with-atypical-pathogenic-structural-variations-overlapping-15q11-q13-imprinting-region
#18
JOURNAL ARTICLE
Rabeya Akter Mim, Anjana Soorajkumar, Noor Kosaji, Muhammad Mizanur Rahman, Shaoli Sarker, Noushad Karuvantevida, Tamannyat Binte Eshaque, Md Atikur Rahaman, Amirul Islam, Mohammod Shah Jahan Chowdhury, Nusrat Shams, K M Furkan Uddin, Hosneara Akter, Mohammed Uddin
BACKGROUND: The 15q11-q13 region is a genetic locus with genes subject to genomic imprinting, significantly influencing neurodevelopment. Genomic imprinting is an epigenetic phenomenon that causes differential gene expression based on the parent of origin. In most diploid organisms, gene expression typically involves an equal contribution from both maternal and paternal alleles, shaping the phenotype. Nevertheless, in mammals, including humans, mice, and marsupials, the functional equivalence of parental alleles is not universally maintained...
April 2024: Brain and Behavior
https://read.qxmd.com/read/38611542/-agrobacterium-mediated-transformation-of-the-dwarf-soybean-minimax
#19
JOURNAL ARTICLE
Min Shao, Kent F McCue, James G Thomson
This study aims to establish an Agrobacterium -mediated transformation system for use with the 'MiniMax'soybean cultivar. MiniMax is a mutant soybean whose growth cycle is around 90 days, half that of most other soybean varieties, making it an optimal model cultivar to test genes of interest before investing in modification of elite lines. We describe an efficient protocol for Agrobacterium -mediated transformation using MiniMax seeds. It uses a modified 'half seed' regeneration protocol for transgenic soybean production, utilizing the rapid generation MiniMax variety to obtain T1 seeds in approximately 145 days...
April 2, 2024: Plants (Basel, Switzerland)
https://read.qxmd.com/read/38604286/a-sophisticated-virulence-repertoire-and-colistin-resistance-of-citrobacter-freundii-st150-from-a-patient-with-sepsis-admitted-to-icu-in-a-tertiary-care-hospital-in-uganda-east-africa-insight-from-genomic-and-molecular-docking-analyses
#20
JOURNAL ARTICLE
Reuben S Maghembe, Maximilian A K Magulye, Emmanuel Eilu, Simon Sekyanzi, Abdalah Makaranga, Savannah Mwesigwa, Eric Katagirya
Sepsis and multidrug resistance comprise a complex of factors attributable to mortality among intensive care unit (ICU) patients globally. Pathogens implicated in sepsis are diverse, and their virulence and drug resistance remain elusive. From a tertiary care hospital ICU in Uganda, we isolated a Citrobacter freundii strain RSM030 from a patient with sepsis and phenotypically tested it against a panel of 16 antibiotics including imipenem levofloxacin, cotrimoxazole and colistin, among others. We sequenced the organism's genome and integrated multilocus sequencing (MLST), PathogenFinder with Virulence Factor analyzer (VFanalyzer) to establish its pathogenic relevance...
April 9, 2024: Infection, Genetics and Evolution
keyword
keyword
45934
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.